Sub menu

 

 

Gilead Sciences Pty Ltd

Regulatory activities for this sponsor.

Filters applied:Clear all
4 result(s) found, displaying 1 to 4

  • Hepcludex (bulevirtide acetate)

    Prescription medicine decision summary
    Hepcludex (bulevirtide acetate) was approved to treat chronic hepatitis delta virus infection in adults with compensated liver disease.

  • Sunlenca

    Prescription medicine decision summary
    TGA decision: Sunlenca (lenacapavir sodium) is approved to treat multidrug resistant HIV-1 infection.

  • Trodelvy

    Prescription medicine decision summary
    Australian prescription medicine decision summary

  • Veklury

    Prescription medicine decision summary
    TGA decision: Veklury (remdesivir) is provisionally approved to treat Coronavirus Disease 2019 (COVID-19) in adults and adolescents

Help us improve this page